SlideShare a Scribd company logo
1 of 34
Download to read offline
A New Look
Prof Dr Sherif Ahmed Kamel Amer
MD ophthalmology, Cairo University, ICO.Ophth.
Professor & Head of The Ophthalmology Department,
Faculty of Medicine, Beni Suef University.
Supervisor of The Neuro-Ophthalmology
Clinic, National Eye Center (Rod El Farag).
Consultant Neuro_Ophthalmologist, Magrabi Eye
Hospitals, Egypt
 The classic syndrome consists of an acute
vascular insult to the optic nerve leading to
infarction of the optic nerve head.
 The disease presents with a sudden and
painless deterioration of vision, usually
discovered on waking in the morning, and
involving mostly the lower part of the visual
field in one eye
 1.Anterior ischemic optic neuropathy (AION):
Affects anterior part of the optic nerve.
 2.Posterior ischemic optic neuropathy
(commonly abbreviated to PION): This is a rare
type due to acute ischemia of posterior part of
the optic nerve.
 Arteritic AION (A-AION): This is the most
serious type and is dueto giant cell arteritis
(GCA).
 Non-arteritic AION (NA-AION): This is the
usual and the most common one, and consists
of all cases other than GCA
 Predisposing Factors: systemic or local (in the
eye and/or optic nerve head).
 Precipitating Factors: These act as the final
insult, resulting in ischemia of the ONH and
AION. A fall of BP during sleep (nocturnal
arterial hypotension) is an important factor in
this category
 The disk at risk
(subclinical
ischemia) shows the
following signs:
 Small scleral canal
 Crowding of nerve
fibers (Obliterated
Cup).
 Disc hyperemia
25%-40% of fellow eyes are
expected to develop NA-AION
 Optic disc swelling without any visual loss;
this indicates an early sign of non-arteritic
AION.
 Optic disc edema usually lasts for several
months unlike those seen initially with
visual loss.
 It is an infrequent but important subtype of
NA-AION.
 Further loss of vision may be experienced
days or weeks after the initial decrease in
vision.
 In some, a new ischemic episode may be the
cause of the further visual loss.
 Rarely, especially if the loss is intermittent
and gradual, a reversible loss may be seen
that can improve spontaneously.
 The number of cases with bilateral simultaneous
presentation with 20 cases having bilateral
simultaneous acute vascular optic neuropathy.
2
8
2
20
0 5 10 15 20 25
Diabetic
papillopathy
Chronic
Subacute
Acute
The Mode Of Presentation of Eyes With Bilateral Simultaneous
Vascular Optic Neuropathies
Diabetic
Papillopathy
5
20
17
47
0
5
10
15
20
25
30
35
40
45
50
normal disc disk at risk incipient post ischemic
The Condition Of The Optic Nerve of The Other Eye in Cases Presenting
With Acute Unilateral Vascular Optic Neuropathy
2.70%
4.60% 4.60%
22.20%
43.50% 53.70%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
The Total Cummulative Percent Of Major Systemic Risk Factors In Cases
With vascular Optic Neuropathy
 Vascular optic nerve diseases are a group of
diseases caused by deficient vascular supply of
the optic nerve on acute or chronic basis and
take different presentations and courses.
 The term ischemic optic neuropathy with it
subdivision anterior or posterior or arteritic
and non-arteritic is very far beyond explaining
the correct classification of these group of
diseases.
 Diabetic patients showed four types of
presentations:
 (a) the typical acute presentation with pale swelling
and altitudinal field defects
 (b) diabetic papillopathy with marked disc swelling
without pallor
 (c) disc swelling with disc pallor without history of
the acute stage, and
 (d) disc swelling with disc pallor without history of
the acute stage, and with neovascularization of the
disc (NVDs). Presentations other than the acute stage
were always bilateral while the acute presentation
was unilateral and bilateral.
 Diabetic eyes show the following stages of
vascular optic nerve disease disease: (a) disc at
risk (b) incipient stage (c) diabetic papillopathy
(d) Acute vascular optic neuropathy (e) chronic
disease with or without NVDs (f) post ischemic
neuropathy.
 Another special point for eyes associated with
diabetes is the higher incidence of bilateral
simultaneous ischemic acute optic neuropathy.
 The severity of involvement of both eyes was
always variable.
 A new look to the clinical classification is
mandatory in order to make an early
detection of subclinical cases for possible
prophylaxis of susceptible cases.
 The current classification of vascular optic
neuropathies is seriously deficient and does
not describe different stages of the disease..
 Prodromal Vscular Neuropathy :
 Disc at risk
 Fellow discs
 Discs in patients with longstanding,
uncontrolled risk factor, or more
than one risk factor.
 Incipient Vascular Neuropathy: Nerve
head with swelling without visual loss.
 Subacute Vascular Neuropathy:
 Optic disc swelling without pallor associated
with nerve fiber layer hemorrhages and
transient attacks of blurring of vision or
transient field defects.
 Chronic (Slowly Progressive) Vascular
Neuropathy:
 Dry chronic vascular optic neuropathy: slowly
progressive disc ischemia without disc edema not
passing through the acute stage.
 Vascular neuropathy due to anemia
 Wet chronic vascular optic neuropathy: slowly
progressive disc ischemia with disc edema with or
without pallor not passing through the acute stage
 Diabetic vascular neuropathy; Papillopathy
 Acute Vascular Neuropathy:
–Mild with BCVA of 66-612
–Moderated with BCVA of 618-636
–Acute profound with BCVA of 660 or less
–Acute recurrent.
 Post Ischemic Optic Neuropathy
 – On top of acute.
 – On top chronic.
Ueda2015 vascular optic neuropathies dr.sherif kamel

More Related Content

What's hot

Ischemic of optic neuropathy, Optic Neuropathy (Ischemic), Eye Stroke
Ischemic of optic neuropathy, Optic Neuropathy (Ischemic), Eye Stroke  Ischemic of optic neuropathy, Optic Neuropathy (Ischemic), Eye Stroke
Ischemic of optic neuropathy, Optic Neuropathy (Ischemic), Eye Stroke Mahavir Mohire
 
AION Anterior Ischemic Optic Neuropathy
AION Anterior Ischemic Optic NeuropathyAION Anterior Ischemic Optic Neuropathy
AION Anterior Ischemic Optic NeuropathyNoor Munirah Aab
 
Transient visual loss localization and visual field interpretation
Transient visual loss localization and visual field interpretationTransient visual loss localization and visual field interpretation
Transient visual loss localization and visual field interpretationVisionary Ophthamology
 
GRAND ROUNDS : Anterior ischemic optic neuropathy with empty sella
GRAND ROUNDS : Anterior ischemic optic neuropathy with empty sellaGRAND ROUNDS : Anterior ischemic optic neuropathy with empty sella
GRAND ROUNDS : Anterior ischemic optic neuropathy with empty sellaSumeet Agrawal
 
Ischemic Optic Neuropathy: A Sequala of Spinal Surgery
Ischemic Optic Neuropathy: A Sequala of Spinal SurgeryIschemic Optic Neuropathy: A Sequala of Spinal Surgery
Ischemic Optic Neuropathy: A Sequala of Spinal Surgerynsahmedod
 
Metabolic optic neuropathies
Metabolic optic neuropathiesMetabolic optic neuropathies
Metabolic optic neuropathiesAmr Hassan
 
Optic neuritis & optic atrophy
Optic neuritis & optic atrophyOptic neuritis & optic atrophy
Optic neuritis & optic atrophySajal Bansod
 
approaches to pale disc
approaches to pale discapproaches to pale disc
approaches to pale discPrajakta Matey
 
Differential Diagnosis of Disc Edema
Differential Diagnosis of Disc EdemaDifferential Diagnosis of Disc Edema
Differential Diagnosis of Disc EdemaSahil Thakur
 
Optic nerve Diseases By: Sumayya Naseem Optometrist
Optic nerve Diseases By: Sumayya Naseem OptometristOptic nerve Diseases By: Sumayya Naseem Optometrist
Optic nerve Diseases By: Sumayya Naseem OptometristSumayya Naseem
 
Optic atrophy and neuroretinitis
Optic atrophy and neuroretinitisOptic atrophy and neuroretinitis
Optic atrophy and neuroretinitisMutahir Shah
 
Swollen optic nerve_presentation_last_revision 103112 disregard all others
Swollen optic nerve_presentation_last_revision 103112 disregard all othersSwollen optic nerve_presentation_last_revision 103112 disregard all others
Swollen optic nerve_presentation_last_revision 103112 disregard all othersArash Eslami
 
Papilledema - Optic Nerve Head Swelling
Papilledema - Optic Nerve Head Swelling Papilledema - Optic Nerve Head Swelling
Papilledema - Optic Nerve Head Swelling Shreeji Shrestha
 
Ocular manifestations of systemic disease
Ocular manifestations of systemic diseaseOcular manifestations of systemic disease
Ocular manifestations of systemic diseaseRiyad Banayot
 

What's hot (20)

Ischemic of optic neuropathy, Optic Neuropathy (Ischemic), Eye Stroke
Ischemic of optic neuropathy, Optic Neuropathy (Ischemic), Eye Stroke  Ischemic of optic neuropathy, Optic Neuropathy (Ischemic), Eye Stroke
Ischemic of optic neuropathy, Optic Neuropathy (Ischemic), Eye Stroke
 
AION Anterior Ischemic Optic Neuropathy
AION Anterior Ischemic Optic NeuropathyAION Anterior Ischemic Optic Neuropathy
AION Anterior Ischemic Optic Neuropathy
 
Transient visual loss localization and visual field interpretation
Transient visual loss localization and visual field interpretationTransient visual loss localization and visual field interpretation
Transient visual loss localization and visual field interpretation
 
GRAND ROUNDS : Anterior ischemic optic neuropathy with empty sella
GRAND ROUNDS : Anterior ischemic optic neuropathy with empty sellaGRAND ROUNDS : Anterior ischemic optic neuropathy with empty sella
GRAND ROUNDS : Anterior ischemic optic neuropathy with empty sella
 
Ischemic Optic Neuropathy: A Sequala of Spinal Surgery
Ischemic Optic Neuropathy: A Sequala of Spinal SurgeryIschemic Optic Neuropathy: A Sequala of Spinal Surgery
Ischemic Optic Neuropathy: A Sequala of Spinal Surgery
 
Metabolic optic neuropathies
Metabolic optic neuropathiesMetabolic optic neuropathies
Metabolic optic neuropathies
 
Approach to vision loss
Approach to vision lossApproach to vision loss
Approach to vision loss
 
Optic neuritis & optic atrophy
Optic neuritis & optic atrophyOptic neuritis & optic atrophy
Optic neuritis & optic atrophy
 
approaches to pale disc
approaches to pale discapproaches to pale disc
approaches to pale disc
 
Differential Diagnosis of Disc Edema
Differential Diagnosis of Disc EdemaDifferential Diagnosis of Disc Edema
Differential Diagnosis of Disc Edema
 
Glaucomatous Optic Atrophy
Glaucomatous Optic AtrophyGlaucomatous Optic Atrophy
Glaucomatous Optic Atrophy
 
Optic nerve Diseases By: Sumayya Naseem Optometrist
Optic nerve Diseases By: Sumayya Naseem OptometristOptic nerve Diseases By: Sumayya Naseem Optometrist
Optic nerve Diseases By: Sumayya Naseem Optometrist
 
Optic atrophy and neuroretinitis
Optic atrophy and neuroretinitisOptic atrophy and neuroretinitis
Optic atrophy and neuroretinitis
 
Swollen optic nerve_presentation_last_revision 103112 disregard all others
Swollen optic nerve_presentation_last_revision 103112 disregard all othersSwollen optic nerve_presentation_last_revision 103112 disregard all others
Swollen optic nerve_presentation_last_revision 103112 disregard all others
 
Optic disc swelling
Optic disc swellingOptic disc swelling
Optic disc swelling
 
Dd of disc edema
Dd of disc edemaDd of disc edema
Dd of disc edema
 
PAPILLEDEMA
PAPILLEDEMAPAPILLEDEMA
PAPILLEDEMA
 
Papilledema - Optic Nerve Head Swelling
Papilledema - Optic Nerve Head Swelling Papilledema - Optic Nerve Head Swelling
Papilledema - Optic Nerve Head Swelling
 
Neuro-ophthalmology
Neuro-ophthalmologyNeuro-ophthalmology
Neuro-ophthalmology
 
Ocular manifestations of systemic disease
Ocular manifestations of systemic diseaseOcular manifestations of systemic disease
Ocular manifestations of systemic disease
 

Similar to Ueda2015 vascular optic neuropathies dr.sherif kamel

Clinical approach to optic neuropathies dove med press
Clinical approach to optic neuropathies dove med pressClinical approach to optic neuropathies dove med press
Clinical approach to optic neuropathies dove med pressneurophq8
 
Optic atrophy
Optic atrophyOptic atrophy
Optic atrophyChrisPius
 
Myopic maculopathy in Pathological Myopia
Myopic maculopathy in Pathological MyopiaMyopic maculopathy in Pathological Myopia
Myopic maculopathy in Pathological MyopiaVivek Chaudhary
 
Altitudinal Visual Field Defect.pptx
Altitudinal Visual Field Defect.pptxAltitudinal Visual Field Defect.pptx
Altitudinal Visual Field Defect.pptxtaebreze
 
Normal Tension Glaucoma.pptx
Normal Tension Glaucoma.pptxNormal Tension Glaucoma.pptx
Normal Tension Glaucoma.pptxAzizul Islam
 
Approach to monocular blindness
Approach to monocular blindnessApproach to monocular blindness
Approach to monocular blindnessNeurologyKota
 
ISCHEMIC OPTIC NEUROPATHIES.pptx
ISCHEMIC OPTIC NEUROPATHIES.pptxISCHEMIC OPTIC NEUROPATHIES.pptx
ISCHEMIC OPTIC NEUROPATHIES.pptxRishabhtrivedi22
 
Optic neuritis
Optic neuritisOptic neuritis
Optic neuritisfaqar2003
 
glaucoma and cataract.pdf
glaucoma and cataract.pdfglaucoma and cataract.pdf
glaucoma and cataract.pdfJishaSrivastava
 
Optic neuritis treatment trial
Optic neuritis treatment trialOptic neuritis treatment trial
Optic neuritis treatment trialVinitkumar MJ
 
Optic neuritis.Neuroophthalmology, Teaching Slides, Dr M D Mohire, Kolhapur, ...
Optic neuritis.Neuroophthalmology, Teaching Slides, Dr M D Mohire, Kolhapur, ...Optic neuritis.Neuroophthalmology, Teaching Slides, Dr M D Mohire, Kolhapur, ...
Optic neuritis.Neuroophthalmology, Teaching Slides, Dr M D Mohire, Kolhapur, ...Mahavir Mohire
 

Similar to Ueda2015 vascular optic neuropathies dr.sherif kamel (20)

Clinical approach to optic neuropathies dove med press
Clinical approach to optic neuropathies dove med pressClinical approach to optic neuropathies dove med press
Clinical approach to optic neuropathies dove med press
 
disc edema.pptx
disc edema.pptxdisc edema.pptx
disc edema.pptx
 
Optic atrophy
Optic atrophyOptic atrophy
Optic atrophy
 
Loss of Vision.pptx
Loss of Vision.pptxLoss of Vision.pptx
Loss of Vision.pptx
 
Myopic maculopathy in Pathological Myopia
Myopic maculopathy in Pathological MyopiaMyopic maculopathy in Pathological Myopia
Myopic maculopathy in Pathological Myopia
 
Altitudinal Visual Field Defect.pptx
Altitudinal Visual Field Defect.pptxAltitudinal Visual Field Defect.pptx
Altitudinal Visual Field Defect.pptx
 
Normal Tension Glaucoma.pptx
Normal Tension Glaucoma.pptxNormal Tension Glaucoma.pptx
Normal Tension Glaucoma.pptx
 
Approach to monocular blindness
Approach to monocular blindnessApproach to monocular blindness
Approach to monocular blindness
 
ISCHEMIC OPTIC NEUROPATHIES.pptx
ISCHEMIC OPTIC NEUROPATHIES.pptxISCHEMIC OPTIC NEUROPATHIES.pptx
ISCHEMIC OPTIC NEUROPATHIES.pptx
 
cataract.pptx
cataract.pptxcataract.pptx
cataract.pptx
 
Vision Impairments
Vision ImpairmentsVision Impairments
Vision Impairments
 
Optic neuritis
Optic neuritisOptic neuritis
Optic neuritis
 
Glaucoma.pptx
Glaucoma.pptxGlaucoma.pptx
Glaucoma.pptx
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
Ophthalmology 5th year, 7th lecture (Dr. Khalid)
Ophthalmology 5th year, 7th lecture (Dr. Khalid)Ophthalmology 5th year, 7th lecture (Dr. Khalid)
Ophthalmology 5th year, 7th lecture (Dr. Khalid)
 
glaucoma and cataract.pdf
glaucoma and cataract.pdfglaucoma and cataract.pdf
glaucoma and cataract.pdf
 
Optic neuritis treatment trial
Optic neuritis treatment trialOptic neuritis treatment trial
Optic neuritis treatment trial
 
Optic neuritis.Neuroophthalmology, Teaching Slides, Dr M D Mohire, Kolhapur, ...
Optic neuritis.Neuroophthalmology, Teaching Slides, Dr M D Mohire, Kolhapur, ...Optic neuritis.Neuroophthalmology, Teaching Slides, Dr M D Mohire, Kolhapur, ...
Optic neuritis.Neuroophthalmology, Teaching Slides, Dr M D Mohire, Kolhapur, ...
 
03 lecture neuro
03 lecture neuro03 lecture neuro
03 lecture neuro
 
Chronic visual loss
Chronic visual lossChronic visual loss
Chronic visual loss
 

More from ueda2015

قنديل ام هاشم يحيى حقى
قنديل ام هاشم يحيى حقىقنديل ام هاشم يحيى حقى
قنديل ام هاشم يحيى حقىueda2015
 
Diabetesforall emad
Diabetesforall emadDiabetesforall emad
Diabetesforall emadueda2015
 
Diabetesforall emad
Diabetesforall emadDiabetesforall emad
Diabetesforall emadueda2015
 
Diabetesforall emad
Diabetesforall emadDiabetesforall emad
Diabetesforall emadueda2015
 
Ueda2016 workshop - hypoglycemia1 -lobna el toony
Ueda2016 workshop - hypoglycemia1 -lobna el toonyUeda2016 workshop - hypoglycemia1 -lobna el toony
Ueda2016 workshop - hypoglycemia1 -lobna el toonyueda2015
 
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewaisUeda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewaisueda2015
 
Ueda2016 workshop - diabetes in the elderly - mesbah kamel
Ueda2016 workshop - diabetes in the elderly  - mesbah kamelUeda2016 workshop - diabetes in the elderly  - mesbah kamel
Ueda2016 workshop - diabetes in the elderly - mesbah kamelueda2015
 
Ueda2016 woman’s health & diabetes - lobna el toony
Ueda2016 woman’s health & diabetes - lobna el toonyUeda2016 woman’s health & diabetes - lobna el toony
Ueda2016 woman’s health & diabetes - lobna el toonyueda2015
 
Ueda2016 wark shop - insulin therapy - mohamed mashahit
Ueda2016 wark shop - insulin therapy  - mohamed mashahitUeda2016 wark shop - insulin therapy  - mohamed mashahit
Ueda2016 wark shop - insulin therapy - mohamed mashahitueda2015
 
Ueda2016 wark shop - insulin pens - precise injection technique - khaled el...
Ueda2016 wark shop - insulin pens - precise injection technique -   khaled el...Ueda2016 wark shop - insulin pens - precise injection technique -   khaled el...
Ueda2016 wark shop - insulin pens - precise injection technique - khaled el...ueda2015
 
Ueda2016 type 1 diabetes guidelines - hesham el hefnawy
Ueda2016 type 1 diabetes guidelines - hesham el hefnawyUeda2016 type 1 diabetes guidelines - hesham el hefnawy
Ueda2016 type 1 diabetes guidelines - hesham el hefnawyueda2015
 
Ueda2016 tobacco and nc ds - wael safwat
Ueda2016 tobacco and nc ds -  wael safwatUeda2016 tobacco and nc ds -  wael safwat
Ueda2016 tobacco and nc ds - wael safwatueda2015
 
Ueda2016 thyroid nodule in practice - khaled el hadidy
Ueda2016 thyroid nodule in practice - khaled el hadidyUeda2016 thyroid nodule in practice - khaled el hadidy
Ueda2016 thyroid nodule in practice - khaled el hadidyueda2015
 
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...ueda2015
 
Ueda2016 the agenda for ncd prevention and control - samer jabbour
Ueda2016 the agenda for ncd prevention and control -  samer jabbourUeda2016 the agenda for ncd prevention and control -  samer jabbour
Ueda2016 the agenda for ncd prevention and control - samer jabbourueda2015
 
Ueda2016 recommendations for management of diabetes during ramadan - update 2...
Ueda2016 recommendations for management of diabetes during ramadan - update 2...Ueda2016 recommendations for management of diabetes during ramadan - update 2...
Ueda2016 recommendations for management of diabetes during ramadan - update 2...ueda2015
 
Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...
Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...
Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...ueda2015
 
Ueda2016 pitfalls in df - hanan gawish
Ueda2016 pitfalls in df - hanan gawishUeda2016 pitfalls in df - hanan gawish
Ueda2016 pitfalls in df - hanan gawishueda2015
 
Ueda2016 non pharmacological diabetes management - emad hamed
Ueda2016 non pharmacological diabetes management   - emad hamedUeda2016 non pharmacological diabetes management   - emad hamed
Ueda2016 non pharmacological diabetes management - emad hamedueda2015
 
Ueda2016 nc ds alliances - adel el sayed
Ueda2016 nc ds alliances - adel el sayedUeda2016 nc ds alliances - adel el sayed
Ueda2016 nc ds alliances - adel el sayedueda2015
 

More from ueda2015 (20)

قنديل ام هاشم يحيى حقى
قنديل ام هاشم يحيى حقىقنديل ام هاشم يحيى حقى
قنديل ام هاشم يحيى حقى
 
Diabetesforall emad
Diabetesforall emadDiabetesforall emad
Diabetesforall emad
 
Diabetesforall emad
Diabetesforall emadDiabetesforall emad
Diabetesforall emad
 
Diabetesforall emad
Diabetesforall emadDiabetesforall emad
Diabetesforall emad
 
Ueda2016 workshop - hypoglycemia1 -lobna el toony
Ueda2016 workshop - hypoglycemia1 -lobna el toonyUeda2016 workshop - hypoglycemia1 -lobna el toony
Ueda2016 workshop - hypoglycemia1 -lobna el toony
 
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewaisUeda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
 
Ueda2016 workshop - diabetes in the elderly - mesbah kamel
Ueda2016 workshop - diabetes in the elderly  - mesbah kamelUeda2016 workshop - diabetes in the elderly  - mesbah kamel
Ueda2016 workshop - diabetes in the elderly - mesbah kamel
 
Ueda2016 woman’s health & diabetes - lobna el toony
Ueda2016 woman’s health & diabetes - lobna el toonyUeda2016 woman’s health & diabetes - lobna el toony
Ueda2016 woman’s health & diabetes - lobna el toony
 
Ueda2016 wark shop - insulin therapy - mohamed mashahit
Ueda2016 wark shop - insulin therapy  - mohamed mashahitUeda2016 wark shop - insulin therapy  - mohamed mashahit
Ueda2016 wark shop - insulin therapy - mohamed mashahit
 
Ueda2016 wark shop - insulin pens - precise injection technique - khaled el...
Ueda2016 wark shop - insulin pens - precise injection technique -   khaled el...Ueda2016 wark shop - insulin pens - precise injection technique -   khaled el...
Ueda2016 wark shop - insulin pens - precise injection technique - khaled el...
 
Ueda2016 type 1 diabetes guidelines - hesham el hefnawy
Ueda2016 type 1 diabetes guidelines - hesham el hefnawyUeda2016 type 1 diabetes guidelines - hesham el hefnawy
Ueda2016 type 1 diabetes guidelines - hesham el hefnawy
 
Ueda2016 tobacco and nc ds - wael safwat
Ueda2016 tobacco and nc ds -  wael safwatUeda2016 tobacco and nc ds -  wael safwat
Ueda2016 tobacco and nc ds - wael safwat
 
Ueda2016 thyroid nodule in practice - khaled el hadidy
Ueda2016 thyroid nodule in practice - khaled el hadidyUeda2016 thyroid nodule in practice - khaled el hadidy
Ueda2016 thyroid nodule in practice - khaled el hadidy
 
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
 
Ueda2016 the agenda for ncd prevention and control - samer jabbour
Ueda2016 the agenda for ncd prevention and control -  samer jabbourUeda2016 the agenda for ncd prevention and control -  samer jabbour
Ueda2016 the agenda for ncd prevention and control - samer jabbour
 
Ueda2016 recommendations for management of diabetes during ramadan - update 2...
Ueda2016 recommendations for management of diabetes during ramadan - update 2...Ueda2016 recommendations for management of diabetes during ramadan - update 2...
Ueda2016 recommendations for management of diabetes during ramadan - update 2...
 
Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...
Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...
Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...
 
Ueda2016 pitfalls in df - hanan gawish
Ueda2016 pitfalls in df - hanan gawishUeda2016 pitfalls in df - hanan gawish
Ueda2016 pitfalls in df - hanan gawish
 
Ueda2016 non pharmacological diabetes management - emad hamed
Ueda2016 non pharmacological diabetes management   - emad hamedUeda2016 non pharmacological diabetes management   - emad hamed
Ueda2016 non pharmacological diabetes management - emad hamed
 
Ueda2016 nc ds alliances - adel el sayed
Ueda2016 nc ds alliances - adel el sayedUeda2016 nc ds alliances - adel el sayed
Ueda2016 nc ds alliances - adel el sayed
 

Ueda2015 vascular optic neuropathies dr.sherif kamel

  • 1. A New Look Prof Dr Sherif Ahmed Kamel Amer MD ophthalmology, Cairo University, ICO.Ophth. Professor & Head of The Ophthalmology Department, Faculty of Medicine, Beni Suef University. Supervisor of The Neuro-Ophthalmology Clinic, National Eye Center (Rod El Farag). Consultant Neuro_Ophthalmologist, Magrabi Eye Hospitals, Egypt
  • 2.  The classic syndrome consists of an acute vascular insult to the optic nerve leading to infarction of the optic nerve head.  The disease presents with a sudden and painless deterioration of vision, usually discovered on waking in the morning, and involving mostly the lower part of the visual field in one eye
  • 3.  1.Anterior ischemic optic neuropathy (AION): Affects anterior part of the optic nerve.  2.Posterior ischemic optic neuropathy (commonly abbreviated to PION): This is a rare type due to acute ischemia of posterior part of the optic nerve.
  • 4.  Arteritic AION (A-AION): This is the most serious type and is dueto giant cell arteritis (GCA).  Non-arteritic AION (NA-AION): This is the usual and the most common one, and consists of all cases other than GCA
  • 5.  Predisposing Factors: systemic or local (in the eye and/or optic nerve head).  Precipitating Factors: These act as the final insult, resulting in ischemia of the ONH and AION. A fall of BP during sleep (nocturnal arterial hypotension) is an important factor in this category
  • 6.  The disk at risk (subclinical ischemia) shows the following signs:  Small scleral canal  Crowding of nerve fibers (Obliterated Cup).  Disc hyperemia 25%-40% of fellow eyes are expected to develop NA-AION
  • 7.  Optic disc swelling without any visual loss; this indicates an early sign of non-arteritic AION.  Optic disc edema usually lasts for several months unlike those seen initially with visual loss.
  • 8.  It is an infrequent but important subtype of NA-AION.  Further loss of vision may be experienced days or weeks after the initial decrease in vision.  In some, a new ischemic episode may be the cause of the further visual loss.  Rarely, especially if the loss is intermittent and gradual, a reversible loss may be seen that can improve spontaneously.
  • 9.
  • 10.
  • 11.
  • 12.  The number of cases with bilateral simultaneous presentation with 20 cases having bilateral simultaneous acute vascular optic neuropathy. 2 8 2 20 0 5 10 15 20 25 Diabetic papillopathy Chronic Subacute Acute The Mode Of Presentation of Eyes With Bilateral Simultaneous Vascular Optic Neuropathies
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 19.
  • 20. 5 20 17 47 0 5 10 15 20 25 30 35 40 45 50 normal disc disk at risk incipient post ischemic The Condition Of The Optic Nerve of The Other Eye in Cases Presenting With Acute Unilateral Vascular Optic Neuropathy
  • 21.
  • 22.
  • 23.
  • 24. 2.70% 4.60% 4.60% 22.20% 43.50% 53.70% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% The Total Cummulative Percent Of Major Systemic Risk Factors In Cases With vascular Optic Neuropathy
  • 25.  Vascular optic nerve diseases are a group of diseases caused by deficient vascular supply of the optic nerve on acute or chronic basis and take different presentations and courses.  The term ischemic optic neuropathy with it subdivision anterior or posterior or arteritic and non-arteritic is very far beyond explaining the correct classification of these group of diseases.
  • 26.  Diabetic patients showed four types of presentations:  (a) the typical acute presentation with pale swelling and altitudinal field defects  (b) diabetic papillopathy with marked disc swelling without pallor  (c) disc swelling with disc pallor without history of the acute stage, and  (d) disc swelling with disc pallor without history of the acute stage, and with neovascularization of the disc (NVDs). Presentations other than the acute stage were always bilateral while the acute presentation was unilateral and bilateral.
  • 27.  Diabetic eyes show the following stages of vascular optic nerve disease disease: (a) disc at risk (b) incipient stage (c) diabetic papillopathy (d) Acute vascular optic neuropathy (e) chronic disease with or without NVDs (f) post ischemic neuropathy.  Another special point for eyes associated with diabetes is the higher incidence of bilateral simultaneous ischemic acute optic neuropathy.  The severity of involvement of both eyes was always variable.
  • 28.  A new look to the clinical classification is mandatory in order to make an early detection of subclinical cases for possible prophylaxis of susceptible cases.  The current classification of vascular optic neuropathies is seriously deficient and does not describe different stages of the disease..
  • 29.  Prodromal Vscular Neuropathy :  Disc at risk  Fellow discs  Discs in patients with longstanding, uncontrolled risk factor, or more than one risk factor.  Incipient Vascular Neuropathy: Nerve head with swelling without visual loss.
  • 30.  Subacute Vascular Neuropathy:  Optic disc swelling without pallor associated with nerve fiber layer hemorrhages and transient attacks of blurring of vision or transient field defects.
  • 31.  Chronic (Slowly Progressive) Vascular Neuropathy:  Dry chronic vascular optic neuropathy: slowly progressive disc ischemia without disc edema not passing through the acute stage.  Vascular neuropathy due to anemia  Wet chronic vascular optic neuropathy: slowly progressive disc ischemia with disc edema with or without pallor not passing through the acute stage  Diabetic vascular neuropathy; Papillopathy
  • 32.  Acute Vascular Neuropathy: –Mild with BCVA of 66-612 –Moderated with BCVA of 618-636 –Acute profound with BCVA of 660 or less –Acute recurrent.
  • 33.  Post Ischemic Optic Neuropathy  – On top of acute.  – On top chronic.